Trexquant Investment’s Janux Therapeutics JANX Stock Holding History

Trexquant Investment’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$973K	Buy	+63,355	New	+$918K	0.01%	1471
2026 Q1	–	Sell	-170,484	Closed	-$2.35M	–	1899
2025 Q4	$2.35M	Buy	170,484 +157,267	+1,190%	+$3.7M	0.02%	932
2025 Q3	$323K	Sell	13,217 -82,957	-86%	-$2.02M	﹤0.01%	1417
2025 Q2	$2.22M	Sell	96,174 -72,798	-43%	-$1.92M	0.03%	850
2025 Q1	$4.56M	Buy	168,972 +103,114	+157%	+$3.89M	0.05%	541
2024 Q4	$3.53M	Buy	+65,858	New	+$3.48M	0.04%	653
2023 Q4	–	Sell	-11,773	Closed	-$119K	–	1612
2023 Q3	$119K	Buy	+11,773	New	+$136K	﹤0.01%	1389

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Trexquant Investment's JANX Position: Q2 2026 in Review

Trexquant Investment opened a new position in Janux Therapeutics (JANX) in Q2 2026: 63,355 shares worth $973K. The stake represents 0.01% of the portfolio and ranks #1471 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in JANX as recently as Q4 2025.

Trexquant Investment first reported a position in JANX in Q3 2023 and has held it in 7 quarters since. The position peaked at $4.56M in Q1 2025. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Trexquant Investment held 63,355 shares of Janux Therapeutics worth $973K as of Q2 2026.
Janux Therapeutics was a new Trexquant Investment position in Q2 2026.
Janux Therapeutics made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1471 holding.
Trexquant Investment first reported a position in Janux Therapeutics in Q3 2023 and has held it in 7 quarters since.
Trexquant Investment's Janux Therapeutics position peaked at $4.56M in Q1 2025.
198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.